当前位置: 首页? 政策法规? 国外法规? 欧盟制定卵传铁蛋白的最大残留限野/a>

欧盟制定卵传铁蛋白的最大残留限野/h1>
扫描二维 分享好友和朋友圈
放大字体缩小字体2019-02-19 10:42:03 来源9a href="https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=uriserv:OJ.L_.2019.039.01.0004.01.ENG" target="_blank" rel="nofollow">欧盟委员伙/a> 浏览次数9span id="hits">4630
核心提示:该法规规定了卵转铁蛋白在鸡肉及其他禽肉中无最大残留限量要求,并且规定该物质在鸡肉中仅可以用作吸入剂使用;在其他禽肉中仅可以用作吸入剂,且不得用于产蛋的动物、/div>
发布单位
欧盟健康与食品安全署,欧盟委员
欧盟健康与食品安全署,欧盟委员伙/div>
发布文号 实施法规 (EU) 2019/238
发布日期 2019-02-08 生效日期 2019-02-28
有效性状?/th> 废止日期 暂无
属?/th> 法规 专业属?/th> 限量相关
备注 该法规规定了卵转铁蛋白在鸡肉及其他禽肉中无最大残留限量要求,并且规定该物质在鸡肉中仅可以用作吸入剂使用;在其他禽肉中仅可以用作吸入剂,且不得用于产蛋的动物、/td>
COMMISSION IMPLEMENTING REGULATION (EU) 2019/238

of 8 February 2019

amending Regulation (EU) No 37/2010 to classify the substance ovotransferrin as regards its maximum residue limit

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and the Council(1), and in particular Article 14 in conjunction with Article 17 thereof,

Having regard to the opinion of the European Medicines Agency formulated on 19 July 2018 by the Committee for Medicinal Products for Veterinary Use,

Whereas:

(1) Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (MRL) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a Regulation.

(2) Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.

(3) The substance ovotransferrin is not included in that table.

(4) An application for the establishment of MRLs for ovotransferrin in chicken tissues and eggs has been submitted to the European Medicines Agency (EMA).

(5) The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended that the establishment of an MRL for ovotransferrin in chicken is not necessary for the protection of human health.

(6) According to Article 5 of Regulation (EC) No 470/2009, the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.

(7) The EMA has considered that the extrapolation of the no MRL required classification for ovotransferrin from chicken tissue to the tissue of other poultry species is appropriate.

(8) Regulation (EU) No 37/2010 should therefore be amended accordingly.

(9) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in theOfficial Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 8 February 2019.

For the Commission

The President

Jean-Claude JUNCKER

(1)OJ?L?152, 16.6.2009, p.?11.

(2)Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ?L?15, 20.1.2010, p.?1).

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:

Pharmacologically active substance

Marker residue

Animal Species

MRLs

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

Ovotransferrin

NOT APPLICABLE

Chicken

No MRL required

NOT APPLICABLE

For inhalation use only

Anti-infectious agent

All poultry except chicken

No MRL required

NOT APPLICABLE

For inhalation use only

Not for use in animals from which eggs are produced

Top

地区9/font>欧盟
标签9/font>最大残留限?nbsp;蛋白禽肉
食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务、br/>电询?535-2129301
QQ?891238009
食品标法? border=
实时把握 食品标法动?/span>
请扫码关?span class="color2">食品标法圇/span>

声明9/p>

凡本网所有原?编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”、br> 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责、br> 邮箱:law#www.sqrdapp.com(发邮件时请?换成@ QQ?39307733

[ 政策法规搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]


按分类浏觇/strong>
推荐国外法规
点击排行
    按国家或地区浏览

    法规中心 关于我们 广告业务 联系我们 信息服务

    Processed in 0.172 second(s), 10 queries, Memory 4.47 M
    Baidu
    map